Rainbow Child. Q1 FY27 Earnings Call — Analysis (NSE: RAINBOW)
Rainbow Children's Q1 FY27 revenue up 33% YoY; announces entry into Mumbai and targets doubling revenue in 4 years
The take
Q1FY27 Revenue ₹470 Cr ( +33% YoY ) . New guidance — FY27 fy27 revenue ₹2,000 Cr . New story: National expansion beyond South India .
Results
Revenue ₹470 Cr +33% YoY; EBITDA ₹134.6 Cr +30% YoY; PAT ₹62.5 Cr +16% YoY; EBITDA margin 28.6%
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Revenue | ₹470 Cr | +33% | yoy · Q1FY27 |
| EBITDA | ₹134.6 Cr | +30% | yoy · Q1FY27 |
| EBITDA Margin | 28.6% | point_in_time · Q1FY27 · Q1FY26 margin not explicitly compared | |
| PAT | ₹62.5 Cr | +16% | yoy · Q1FY27 |
| Cash & Investments | ₹613 Cr | point_in_time · Jun-26 · as of June 30, 2026 | |
| Operational Beds | 1,862 | +22% | yoy · Q1FY27 · vs Q1FY26 |
| Occupancy | 41% | point_in_time · Q1FY27 · improved from prior period, not quantified | |
| ARPOB (Mature Hospitals) | ₹70,000 | point_in_time · Q1FY27 · hospitals >5 years old | |
| ARPOB (New Hospitals) | ₹59,000 | point_in_time · Q1FY27 · hospitals <5 years old | |
| Inpatient Discharges Growth | 28% | +28% | yoy · Q1FY27 |
| OPD Consultations Growth | 25% | +25% | yoy · Q1FY27 |
| Deliveries Growth | 23% | +23% | yoy · Q1FY27 |
Guidance
Revenue expected to cross ₹2,000 Cr in FY27 and double over next 4 years; Q2FY27 revenue growth above 20%; pre-Ind AS EBITDA margin guided to 24–25% by FY27 end
What management committed to
- The [Malad, Mumbai] brownfield hospital (100 beds) is expected to commence operations in Q1 FY28. — Q1FY28
- The additional 30-bed Maternal Care Block at [Nellore Prime Children's Hospital] is expected to commence operations within 6 months [by end of Q4FY27]. — Q4FY27
- The [Guntur] 50-bed hospital will commence operations in a couple of months' time [by Q2FY27]. — Q2FY27
- Indore hospital is on track to commence operations in Q3 FY27. — Q3FY27
- Regional hub hospital in Coimbatore and spoke hospital in Gurgaon Sector 56 are expected to commence operations in Q3 FY28. — Q3FY28
- Hub hospital in Gurgaon Sector 44 is expected to commence operations in Q1 FY29. — Q1FY29
- Pune hospital (150 beds) and Spoke hospital in Bangalore Seegehalli are expected to commence operations in FY29. — FY29
- Over the next 5 years, the company plans to add 2,500 beds, expanding network capacity to 5,000 beds, with estimated capex of INR 2,200 crores. — 2,500 beds, 5,000 beds, INR 2,200 crores, FY31
- Revenue expected to cross INR 2,000 crores by the end of this financial year (FY27). — INR 2,000 crores, FY27
- The company has the potential to double [FY27 revenue of ~₹2,000 Cr] over the following four years [by FY31]. — double, FY31
- We expect revenue growth to remain above 20% in Q2 FY27. — above 20%, Q2FY27
- Pre-Ind AS EBITDA margins expected to return to the 24–25% range by the end of FY27. — 24–25%, FY27
Key themes
National expansion, margin recovery, capacity ramp-up
How the narrative shifted
- National expansion beyond South India: Management positions entry into Mumbai, Delhi-NCR, and Central India as transformative, leveraging proven hub-and-spoke model to capture large unmet pediatric need.
- Margin normalization post capacity ramp-up: New hospitals create temporary margin pressure but management guides to 24-25% EBITDA margins by FY27 end as operating leverage and maturity kick in.
- Pediatric super-specialty differentiation: Rainbow's tertiary/quaternary capabilities (transplants, ECMO) and integrated mother-child continuum create competitive moat vs. birthing centres.
- Digital and technology transformation: Investments in CRM, HIS, BI, and data lake to improve patient acquisition, operational visibility, and efficiency.
- Inorganic growth and integration: Acquisitions in Guwahati, Warangal, Nellore, Guntur fill gaps and expand footprint, with integration focus on clinical protocols and cost structures.
- Seasonality risk reduction: Management aims to reduce dependence on seasonal disease patterns through digital outreach and community engagement, though monsoon still important.
- Strong balance sheet to fund capex: Cash reserves of ₹613 Cr and internal accruals provide flexibility for ₹2,200 Cr capex plan without equity dilution.
- Potential entry into government-funded schemes: Management actively evaluating allocating capacity to government schemes to boost occupancy, but cautious on pricing sustainability.
Operational commentary
- Signed definitive agreement for 100-bed brownfield hospital in Malad, Mumbai, marking entry into Western India; expected to commence Q1FY28
- Acquired 70-bed Prime Children's Hospital in Nellore, with additional 30-bed Maternal Care Block to start in 6 months
- Signed long-term lease for 50-bed ready-to-operate hospital in Guntur, commencing in a couple of months
- Announced 5-year plan to add 2,500 beds (to reach 5,000 beds) with capex of ~INR 2,200 Cr; visibility on 1,200 beds under development
- New hospitals ramping: Rajahmundry at breakeven; Electronic City (Bangalore) expected breakeven in 2–3 months
- Indore hospital on track for Q3FY27 commencement; hub Coimbatore & spoke Gurgaon Sec 56 by Q3FY28; hub Gurgaon Sec 44 by Q1FY29; Pune 150-bed & Bangalore Seegehalli by FY29
- ECMO retrieval of child from Guwahati over 1,800 km, one of India's longest paediatric ECMO retrievals; complex trauma case managed with multidisciplinary precision
- Digital initiatives: CRM platform and lead management system implemented; HIS modernisation, BI platform, data lake expected substantially over next 3–4 months
- Occupancy improved to over 41%; inpatient discharges +28%, OPD +25%, deliveries +23% YoY
- Payor mix stable: cash ~48%, insurance ~42%
- Organic revenue growth (ex-acquisitions) 24% YoY; acquisitions contributed INR 38 Cr revenue and ~10% of EBITDA in Q1
Analyst Q&A
Q. Is it right to understand that by the end of this financial year, operational beds should be around 2,050 plus?
We currently have visibility on approximately 1,200 beds that are already in various stages of execution. (No specific FY27-end bed count confirmed)
Q. How has been the start for this quarter (Q2) – could you highlight 2-3 indicators?
It is still too early to comment. The monsoon has been delayed, so we will need to wait and see how the season evolves. July is too early to draw any conclusions.
Q. What are the potential challenges in the Mumbai market and the doctor engagement model?
Higher cost structure but pricing also higher. Core doctors will be on full-time employment model. EBITDA margins should eventually be above 20%, but too early for precise margin expectation.
Research and educational content only. Not investment advice.